Zenas Biopharma Inc
(ZBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZBIO | EYPT | ABCL | ||
| Company | Zenas Biopharma Inc | Eyepoint Inc | Abcellera Biologics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 21.21 | 12.83 | 3.51 | ||
| High | 22.28 | 12.83 | 3.53 | ||
| Low | 20.57 | 12.12 | 3.18 | ||
| Latest | 20.66 | 12.33 | 3.27 | ||
| Change | +0.94 | -0.47 | -0.25 | ||
| % Change | +4.77% | -3.67% | -7.10% | ||
| Volume | 1,264,481 | 1,765,938 | 6,548,486 | ||
| 20-Day Average Volume | 884,759 | 1,070,807 | 4,965,849 | ||
| Previous Close | 19.72 | 12.80 | 3.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.63 | 15.25 | 4.06 | ||
| 20-Day Raw Stochastic | 74.64% | 3.45% | 5.39% | ||
| 20-Day Relative Strength | 43.04 | 33.51 | 37.76 | ||
| Weighted Alpha | +256.16 | +59.27 | -8.91 | ||
| Today's Opinion | 8% Sell | 8% Buy | 56% Sell | ||
| Previous Opinion | 24% Sell | 8% Buy | 48% Sell | ||
| Last Month's Opinion | 8% Buy | 88% Buy | 72% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.77% since 01/28/26 | -18.02% since 01/28/26 | -16.15% since 01/28/26 | ||
| Low | 17.60 on 02/02/26 | 12.12 on 02/04/26 | 3.18 on 02/04/26 | ||
| High | 22.70 on 01/29/26 | 15.31 on 01/29/26 | 3.91 on 01/29/26 | ||
| 1-Month | |||||
| %Chg | -40.12% since 01/02/26 | -29.46% since 01/02/26 | -4.66% since 01/02/26 | ||
| Low | 13.50 on 01/05/26 | 12.12 on 02/04/26 | 3.18 on 02/04/26 | ||
| High | 22.70 on 01/29/26 | 18.20 on 01/07/26 | 4.85 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | -31.02% since 11/04/25 | -0.48% since 11/04/25 | -32.85% since 11/04/25 | ||
| Low | 13.50 on 01/05/26 | 9.65 on 11/05/25 | 3.18 on 02/04/26 | ||
| High | 44.60 on 12/24/25 | 19.11 on 12/08/25 | 4.92 on 11/05/25 | ||
| 6-Month | |||||
| %Chg | +22.90% since 08/04/25 | +22.56% since 08/04/25 | -24.65% since 08/04/25 | ||
| Low | 13.50 on 01/05/26 | 9.40 on 08/05/25 | 3.18 on 02/04/26 | ||
| High | 44.60 on 12/24/25 | 19.11 on 12/08/25 | 6.51 on 10/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,058,550 | 1,059,674 | 1,053,659 | ||
| Shares Outstanding, K | 53,679 | 82,787 | 299,335 | ||
| Annual Sales | 5,000,000 | 43,270,000 | 28,830,000 | ||
| Annual Net Income | -156,990,000 | -130,870,000 | -162,860,000 | ||
| Last Quarter Sales | 0 | 970,000 | 8,960,000 | ||
| Last Quarter Net Income | -52,220,000 | -59,730,000 | -57,120,000 | ||
| 60-Month Beta | -1.50 | 1.76 | 0.81 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.22 on 11/12/25 | -0.85 on 11/05/25 | -0.19 on 11/06/25 | ||
| Latest Earnings Date | 02/11/26 | 03/04/26 | 02/24/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | 12/24/19 | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||